Share on LinkedInShare on LinkedIn

ARTICLE · 10 DECEMBER 2019

Preventive Medicine: Official "Antimonopoly Compliance Guidelines For Business Operators" In China

On 28 November 2019, the State Administration of Market Regulation (SAMR) released for public comment draft "Anti-Monopoly Compliance Guidelines for Operators" (the Draft Guidelines).

ChinaAntitrust/Competition Law

On 28 November 2019, the State Administration of Market Regulation (SAMR) released for public comment draft "Anti-Monopoly Compliance Guidelines for Operators" (the Draft Guidelines).1 These non-binding guidelines recommend measures for "business operators" subject to the Antimonopoly Law (AML) to develop and implement antitrust compliance programmes. The Draft Guidelines integrate prevailing best practices for international compliance programmes, while reflecting the unique challenges of antitrust risk management in China.

Substantive roadmap

The Draft Guidelines provide a roadmap to SAMR's published guidance on the substantive rules against anticompetitive monopoly agreements and abuse of dominance. Participants in monopoly agreements are referred to SAMR's leniency programme for instructions on seeking amnesty or penalty reductions through voluntary disclosure to SAMR. Similarly, companies are advised to comply with merger notification requirements.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from